Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
13.65
-0.06 (-0.44%)
Apr 30, 2025, 3:04 PM CST
SHE:002275 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 8,020 | 8,866 | 8,514 | 7,570 | 9,728 | 8,577 | Upgrade
|
Market Cap Growth | 4.14% | 4.14% | 12.46% | -22.18% | 13.41% | 12.23% | Upgrade
|
Enterprise Value | 6,706 | 7,964 | 7,554 | 6,585 | 8,505 | 7,348 | Upgrade
|
Last Close Price | 13.65 | 15.09 | 13.94 | 12.26 | 14.66 | 12.18 | Upgrade
|
PE Ratio | 19.74 | 17.00 | 20.21 | 22.97 | 28.30 | 30.96 | Upgrade
|
Forward PE | 15.87 | 17.16 | 17.16 | 17.16 | 17.16 | 17.16 | Upgrade
|
PS Ratio | 3.66 | 4.04 | 3.92 | 3.86 | 5.59 | 5.48 | Upgrade
|
PB Ratio | 2.66 | 2.95 | 3.02 | 2.69 | 3.43 | 2.90 | Upgrade
|
P/TBV Ratio | 2.80 | 3.10 | 3.20 | 2.87 | 3.66 | 3.08 | Upgrade
|
P/FCF Ratio | 15.85 | 17.52 | 18.01 | 16.23 | 36.55 | 21.85 | Upgrade
|
P/OCF Ratio | 13.63 | 15.07 | 15.50 | 14.32 | 23.71 | 14.34 | Upgrade
|
EV/Sales Ratio | 3.17 | 3.63 | 3.48 | 3.36 | 4.88 | 4.69 | Upgrade
|
EV/EBITDA Ratio | 12.51 | 11.67 | 13.58 | 15.98 | 20.59 | 18.67 | Upgrade
|
EV/EBIT Ratio | 15.71 | 13.91 | 16.32 | 20.86 | 26.06 | 23.45 | Upgrade
|
EV/FCF Ratio | 13.25 | 15.74 | 15.98 | 14.12 | 31.95 | 18.72 | Upgrade
|
Debt / Equity Ratio | 0.20 | 0.20 | 0.19 | 0.17 | 0.21 | 0.14 | Upgrade
|
Debt / EBITDA Ratio | 0.86 | 0.86 | 0.92 | 1.08 | 1.41 | 1.03 | Upgrade
|
Debt / FCF Ratio | 1.17 | 1.17 | 1.12 | 1.00 | 2.29 | 1.03 | Upgrade
|
Asset Turnover | 0.54 | 0.54 | 0.55 | 0.49 | 0.44 | 0.43 | Upgrade
|
Inventory Turnover | 2.51 | 2.51 | 2.41 | 2.17 | 1.91 | 2.42 | Upgrade
|
Quick Ratio | 2.33 | 2.33 | 2.09 | 2.39 | 2.56 | 3.60 | Upgrade
|
Current Ratio | 2.58 | 2.58 | 2.46 | 2.71 | 2.96 | 4.04 | Upgrade
|
Return on Equity (ROE) | 17.90% | 17.90% | 14.96% | 11.66% | 11.86% | 9.59% | Upgrade
|
Return on Assets (ROA) | 8.76% | 8.76% | 7.32% | 4.90% | 5.11% | 5.37% | Upgrade
|
Return on Capital (ROIC) | 10.30% | 10.30% | 8.73% | 5.86% | 5.99% | 6.08% | Upgrade
|
Return on Capital Employed (ROCE) | 17.70% | 17.70% | 15.20% | 10.10% | 10.00% | 9.50% | Upgrade
|
Earnings Yield | 6.50% | 5.88% | 4.95% | 4.35% | 3.53% | 3.23% | Upgrade
|
FCF Yield | 6.31% | 5.71% | 5.55% | 6.16% | 2.74% | 4.58% | Upgrade
|
Dividend Yield | 4.40% | - | 4.30% | 6.53% | 6.14% | 3.28% | Upgrade
|
Payout Ratio | 64.45% | 64.45% | 101.54% | 173.24% | 132.00% | 52.97% | Upgrade
|
Buyback Yield / Dilution | -0.15% | -0.15% | 0.56% | -2.72% | 0.74% | 1.39% | Upgrade
|
Total Shareholder Return | 4.25% | -0.15% | 4.87% | 3.81% | 6.88% | 4.68% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.